In Brief: Nellcor Puritan Bennett
This article was originally published in The Gray Sheet
Executive Summary
Nellcor Puritan Bennett: Signs exclusive distribution agreement with Transtracheal Systems, Inc. under which NPB gains rights to market the DOC-2000 demand oxygen controller in most of the U.S. and Canada. The DOC-2000 is used with home oxygen therapy systems "to conserve oxygen and minimize waste while maintaining appropriate levels of oxygen for the patient," the firm explains. The device "tracks the respiratory cycle of each individual patient, delivering oxygen on demand while the patient inhales"...